Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Metronomic Therapy in Patients With Metastatic Melanoma [Phase 2]
Phase 2 clinical trial update for metronomic therapy in metastatic melanoma; study terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation [Phase 1]
A Phase 1 trial evaluating the combination of an oral Cdk inhibitor with an oral BRAF inhibitor in patients with advanced or inoperable BRAF…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma [Phase 1]
A Phase 1 safety study evaluating the combination of interleukin-21 with ipilimumab for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]
Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma [Phase 2]
Phase 2 trial of intralesional PV-10 for metastatic melanoma completed; results were posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma [Phase 3]
A Phase 3 trial evaluating ipilimumab versus placebo to prevent recurrence after complete resection of high risk stage III melanoma has comp…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma [Phase 3]
Phase 3 trial comparing trametinib plus dabrafenib vs dabrafenib alone in BRAF-mutant melanoma has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Randomised Study to Compare the Efficacy of AZD6244 vs TMZ [Phase 2]
A Phase 2 randomized trial comparing AZD6244 (selumetinib) versus temozolomide in melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies [Phase 1]
Phase 1 study to evaluate the effect of food on dosing of AZD6244 HydSulfate (selumetinib) in patients with advanced solid malignancies, inc…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery [Phase 3]
Phase 3 trial evaluating sargramostim, vaccine therapy, or combination to prevent melanoma recurrence after surgical removal; study complete…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Patient Preference for Biopsy Notification
This clinical trial update summarizes patient preferences for how biopsy notification is delivered to individuals at elevated risk for melan…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis [Phase 2]
Phase 2 proof-of-concept study evaluating the PET imaging tracer [18F]AH-111585 for detecting tumors and angiogenesis, with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors [Phase 1]
A Phase 1 clinical trial update notes the completion of a biological therapy study in children with refractory or recurrent neuroblastoma or…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma [NA]
A completed clinical trial evaluating a smartphone-based melanoma detection training tool for physicians to improve early diagnosis.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma [Phase 1]
Phase 1 dose-escalation trial assessing safety and tolerability of the allogeneic tumor vaccine BIWB 2 in patients with advanced malignant m…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma [Phase 2]
Phase II study comparing interleukin-21 to dacarbazine in metastatic or recurrent melanoma has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma [Phase 1]
Phase 1 safety study of MORAb-028 (a human IgM monoclonal antibody) for metastatic melanoma has been terminated. No results are provided in …
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma [Phase 1]
Phase 1 safety and dose-determination study of MORAb-028 in metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [Phase 1]
Phase 1 trial evaluating Indium-111 pentetreotide in patients with refractory cancer across multiple tumor types. The study status is termin…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma [NA]
This completed clinical trial studied circulating tumor cells in patients with metastatic melanoma before and after treatment to assess chan…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib [Phase 2]
This Phase 2 trial update reports the combination of selumetinib and MK-2206 in patients with stage III/IV melanoma after progression on vem…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells [Phase 2]
Phase 2 trial evaluating MART-expressing tumor cell therapy for metastatic melanoma; the study was terminated and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases [Phase 2]
This update reports results from a Phase 2 trial evaluating tumor response to ipilimumab in patients with melanoma that has metastasized to …
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial of a vaccine therapy for recurrent/metastatic melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Melaxin cancer vaccine plus Bacillus Calmette-Guérin (BCG) for malignant melanoma was terminated, with results …